Quick Answer
Biomea Fusion, Inc. reported Operating Income Loss of -$83.51 million for the year ending 2025.
- Biomea Fusion, Inc. showed an increase of +42.0% in Operating Income Loss from 2024 to 2025.
- This data is from Biomea Fusion, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$398.0 thousand | Q2 2020: -$295.0 thousand | Q3 2020: -$1.14 million | Q4 2020: -$3.50 million | Q1 2021: -$5.86 million | Q2 2021: -$8.44 million | Q3 2021: -$12.64 million | Q4 2021: -$14.74 million | Q1 2022: -$16.40 million | Q2 2022: -$17.47 million | Q3 2022: -$23.48 million | Q4 2022: -$26.28 million | Q1 2023: -$30.03 million | Q2 2023: -$27.66 million | Q3 2023: -$31.12 million | Q4 2023: -$37.33 million | Q1 2024: -$41.06 million | Q2 2024: -$38.90 million | Q3 2024: -$34.04 million | Q4 2024: -$30.07 million | Q1 2025: -$29.71 million | Q2 2025: -$21.28 million | Q3 2025: -$20.81 million.
- Over the full 7 years of available data (2019 to 2025), Biomea Fusion, Inc.'s Operating Income Loss has declined by 6,888.5%.
- Historical annual values: Fiscal year 2025: -$83.51 million | Fiscal year 2024: -$144.07 million | Fiscal year 2023: -$126.14 million | Fiscal year 2022: -$83.63 million | Fiscal year 2021: -$41.67 million | Fiscal year 2020: -$5.33 million | Fiscal year 2019: -$1.20 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: